Reach Us +44-1202-068036
Z. Yang | OMICS International
ISSN: 2153-0769

Metabolomics:Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Z. Yang

University of Houston


Zhen Yang, Ph.D. is a senior scientist of biopharmaceutics at Merck. Prior to joining Merck, Dr. Yang led a clinical bioanalytical lab as Supervisor at Texas Medical Toxicology for 1 year. Zhen obtained his Ph.D. at University of Houston focusing on oral drug absorption, metabolism, and related drug transporters. In his master program at Shanghai Institute of Pharmaceutical Industry, he worked on development of transdermal drug formulation. Zhen\s main research area is to support oral formulation development at various development stages. In addition, Zhen will lead and collaborate with colleagues in identifying and evaluating opportunities for alternate route of drug delivery in both drug discovery and late stage development.

Research Interest

Biopharmaceutical evaluation, metabolomics, drug delivery systems, Pharmacometabolomics, Clinical Studies


Global Speakers in the subject

Global Experts in the subject